AChE/BuChE/MAO-B-IN-1 structure
|
Common Name | AChE/BuChE/MAO-B-IN-1 | ||
---|---|---|---|---|
CAS Number | 2834758-29-9 | Molecular Weight | 289.37 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C17H23NO3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of AChE/BuChE/MAO-B-IN-1AChE/BuChE/MAO-B-IN-1 (compound 19) is an inhibitor of human acetyl- (hAChE), butyrylcholinesterase (hBuChE) and monoamine oxidase-B (hMAO-B) with IC50s of 4.8 μM, 13.7 μM, and 1.11 μM, respectively. AChE/BuChE/MAO-B-IN-1 also exhibits high affinity to both the σ1 and σ2 receptors with Ki values of 42.8 nM (human σ1 receptor) and 191 nM (rat σ2 receptor), respectively. AChE/BuChE/MAO-B-IN-1 can be used for Alzheimer’s disease research[1]. |
Name | AChE/BuChE/MAO-B-IN-1 |
---|
Description | AChE/BuChE/MAO-B-IN-1 (compound 19) is an inhibitor of human acetyl- (hAChE), butyrylcholinesterase (hBuChE) and monoamine oxidase-B (hMAO-B) with IC50s of 4.8 μM, 13.7 μM, and 1.11 μM, respectively. AChE/BuChE/MAO-B-IN-1 also exhibits high affinity to both the σ1 and σ2 receptors with Ki values of 42.8 nM (human σ1 receptor) and 191 nM (rat σ2 receptor), respectively. AChE/BuChE/MAO-B-IN-1 can be used for Alzheimer’s disease research[1]. |
---|---|
Related Catalog | |
Target |
hAChE:4.8 μM (IC50) hBCHE:13.7 μM (IC50) hMAO-B:1.11 μM (IC50) |
References |
Molecular Formula | C17H23NO3 |
---|---|
Molecular Weight | 289.37 |